Craig S. Shular - 12 Jun 2026 Form 4 Insider Report for MATERION Corp (MTRN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Jun 2026, 13:29:10 UTC
Prior SEC filing
11 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Michelle R. Mekinda, as Attorney-In-Fact

Key filing fact

Craig S. Shular filed Form 4 for MATERION Corp (MTRN) on 16 Jun 2026.

Key facts

  • This page summarizes Craig S. Shular's Form 4 filing for MATERION Corp (MTRN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2026, 13:29.

Change

  • Previous filing in this sequence was filed on 11 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001078942 Primary reporting owner

SHULAR CRAIG S

Relationship
Director
Address
6070 PARKLAND BLVD., MAYFIELD HTS.,
Signature
/s/Michelle R. Mekinda, as Attorney-In-Fact
Signature date
16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTRN transaction

Common Stock

Award

Transaction value
Shares
+31
Change %
+0.06%
Price
$0.000000*
Shares after
54,824
Date
12 Jun 2026
Ownership
Held In Directors Deferred Comp. Plan
MTRN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
5,909
Date
12 Jun 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .